Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$321,112
+$46,388 QoQ
Shares Held
5,727
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#448
of 635 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $1,601,611 across 7 Biotechnology names. RPRX ranks #2 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
4,983 | $1,200,753 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
5,727 | $321,112 | |
| 3 | INCY |
Incyte Corp
|
351 | $39,789 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
60 | $29,803 | |
| 5 | ARVN |
Arvinas, Inc.
|
655 | $5,443 | |
| 6 | NKTR |
Nektar Therapeutics
|
40 | $2,792 | |
| 7 | INSM |
INSMED Inc
|
18 | $1,919 |
All Filings in RPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $321,112 | 5,727 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $274,724 | 5,727 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $221,291 | 5,727 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $167,143 | 4,639 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $144,412 | 4,639 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||